Aarti Pharmalabs Limited
LIC cut its stake in Aarti Pharmalabs from 5.27% to 4.72%, selling 5,00,000 shares. This transaction took its total holding down to 42,82,452 shares, slipping below the 5% regulatory disclosure threshold.
A pharmaceutical and nutraceutical manufacturer, Aarti Pharmalabs produces active pharmaceutical ingredients and finished dosage forms for domestic and international markets. The company specializes in contract manufacturing and custom synthesis services across multiple therapeutic segments including oncology, cardiology, and gastroenterology. Incorporated in 2019, it operates manufacturing facilities designed to meet stringent regulatory standards for pharmaceutical production and quality assurance.
India's largest domestic institutional investor with over Rs 56 lakh crore in total AUM, of which roughly Rs 15 lakh crore sits in listed equities. Holds stakes in virtually every major listed Indian company. When LIC builds or exits a position, it moves markets. Government-owned and mandated to invest policyholder funds in Indian equities and bonds, making it the ultimate long-only, long-term India bull.